Table 2.
Patients (n) | Variant cDNA level | Variant protein level | rs number | Clinvar prediction | References |
---|---|---|---|---|---|
2 | c.74G>T | p.R25L | rs61578124 | Uncertain significance | [16] |
4 | c.82C>T | p.R28W | rs59914820 | Pathogenic | [9–9] |
1 | c.178C>G | p.R60G | rs28928900 | Pathogenic | [20, 21] |
8 | c.184C>G | p.R62G | rs56793579 | Pathogenic | [17, 20] |
1 | c.575A>T | p.D192V | rs57045855 | Not provided | [20] |
2 | c.1045C>T | p.R349W | rs267607555 | Pathogenic/likely pathogenic | [10, 22] |
5 | c.1255C>T | p.R419C | rs755686359 | Uncertain significance | [23] |
4 | c.1394G>A | p.G465D | rs61282106 | Pathogenic | [17] |
5 | c.1445G>T | p.R482L | rs11575937 | Uncertain significance | [17] |
92 | c.1444C>T | p.R482W | rs57920071 | Pathogenic | [17, 6–6] |
96 | c.1445G>A | p.R482Q | rs11575937 | Pathogenic | [17, 6–6] |
1 | c.1458G>T | p.K486N | rs59981161 | Pathogenic | [27] |
1 | c.1488+5G>C | NA | rs267607543 | Pathogenic | [28] |
2 | c.1567G>C | p.G523R | rs201583907 | Uncertain significance | [29] |
2 | c.1580G>C | p.R527P | rs57520892 | Pathogenic | [30] |
3 | c.1583C>T | p.T528M | rs57629361 | Uncertain significance | [31] |
1 | c.1622G>C | p.R541P | rs61444459 | Pathogenic/likely pathogenic | [32] |
1 | c.1744C>T | p.R582C | rs918645468 | Uncertain significance | [22, 33] |
12 | c.1745G>A | p.R582H | rs57830985 | Pathogenic | [17, 26, 34] |
10 | c.1748C>T | p.S583L | rs59601651 | Uncertain significance | [17] |
1 | c.1751G>A | p.R584H | rs56657623 | Uncertain significance | [17, 22] |
1 | c.1930C>T | p.R644C | rs142000963 | Benign; uncertain significance | [17, 35] |
All the variants have been associated with lipodystrophy and published before.
Abbreviation: NA, not available.